Samsung Sdi Co., Inc.

Future Medicine Co., Ltd.

Ji Youn Lee

Jae Wook Yang

Hyuk Woo Lee

Mi Ra Yu

Jee Young Kim

Bo Mi Park

Chong-Woo Park

Eun Kyung Kim

Young Wook Choi

The present disclosure relates to a pharmaceutical composition, an oral administration agent and an eye drop for preventing or treating retinal diseases or optic nerve diseases including the compound represented by the Chemical Formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient and the pharmaceutical composition, the oral administration agent and the eye drop can effectively prevent or treat retinal disease or optic nerve disease.

Pharmaceutical composition comprising adenosine derivative for prevention and treatment of retinal disease or optic nerve disease

A composition for solar cell electrodes, an electrode fabricated using the same, and a solar cell including the electrode, the composition including a conductive powder; a glass frit; and an organic vehicle, wherein the conductive powder includes silver powder and aluminum powder, the silver powder includes silver particles having an average particle size D50 of 1.5 &#x3bc;m or more in an amount of 50 wt % or more, based on a total weight of the silver powder.

Composition for solar cell electrodes, electrode fabricated using the same, and solar cell having the electrode

Growing community of inventors

Suwon-si, South Korea

Ji Youn Lee